Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Acting Anti-viral Therapy.

NCT05465434 PHASE3 COMPLETED

This study aims to evaluate the possible antifibrotic effect of zinc sulphate in chronic HCV patient receiving direct acting anti-viral therapy

Details

Lead sponsor	Tanta University
Phase	PHASE3
Status	COMPLETED
Enrolment	50
Start date	Mon Aug 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Aug 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Hepatitis C

Interventions

• Zinc Supplement

Countries

Egypt